NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [(67)Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Background: The GRPR-antagonist-based radioligands [(67/68)Ga/(111)In/(177)Lu]NeoBOMB1 have shown excellent theragnostic profiles in preclinical prostate cancer models, while [(68)Ga]NeoBOMB1 effectively visualized prostate cancer lesions in patients. We were further interested to explore the therag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaloudi, Aikaterini, Lymperis, Emmanouil, Giarika, Athina, Dalm, Simone, Orlandi, Francesca, Barbato, Donato, Tedesco, Mattia, Maina, Theodosia, de Jong, Marion, Nock, Berthold A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150197/
https://www.ncbi.nlm.nih.gov/pubmed/29137110
http://dx.doi.org/10.3390/molecules22111950

Ejemplares similares

Ejemplares similares